Page last updated: 2024-12-05

2-nitroaniline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID6946
CHEMBL ID274009
SCHEMBL ID11911292
SCHEMBL ID6000
MeSH IDM0581273

Synonyms (105)

Synonym
(2-nitrophenyl)-amine
ONA ,
azoic diazo component 6
orange salt irga ii
2-nitroaniline ,
aniline, o-nitro-
o-nitraniline
diazo fast orange gr
fast orange salt gr
orange salt ciba ii
o-nitroaniline
hiltonil fast orange gr base
nsc9796
devol orange salt b
azoene fast orange gr salt
devol orange b
fast orange gr salt
2-aminonitrobenzene
c.i. 37025
orange base irga ii
azogene fast orange gr
fast orange o salt
wln: zr bnw
orange grs salt
88-74-4
natasol fast orange gr salt
2-nitrobenzenamine
hiltosal fast orange gr salt
brentamine fast orange gr salt
brentamine fast orange gr base
orange base ciba ii
fast orange salt jr
azofix orange gr salt
fast orange base jr
fast orange gr base
fast orange base gr
hindasol orange gr salt
benzenamine, 2-nitro-
nsc-9796
c.i. azoic diazo component 6
1-amino-2-nitrobenzene
azoene fast orange gr base
fast orange o base
o-aminonitrobenzene
2-nitro-aniline
inchi=1/c6h6n2o2/c7-5-3-1-2-4-6(5)8(9)10/h1-4h,7h
NCGC00091373-01
hsdb 1132
ci azoic diazo component 6
orthonitroaniline
nsc 9796
ccris 2317
einecs 201-855-4
ci 37025
ai3-02916
2-nitroaniline, 98%
2-nitroaniline, analytical standard
2-nitro-phenylamine
CHEMBL274009
N0118
AKOS000119116
STL140693
NCGC00091373-02
2519u0541l ,
o-nitroaniline [un1661] [poison]
ortho-nitroaniline
unii-2519u0541l
ec 201-855-4
tox21_303292
dtxsid1025726 ,
dtxcid905726
cas-88-74-4
NCGC00257171-01
NCGC00259920-01
tox21_202371
SCHEMBL11911292
FT-0613173
2-nitroaniline [hsdb]
o-nitroaniline [mi]
nitroaniline, o-
BP-21264
SCHEMBL6000
(2-nitro-phenyl)-amine
2-nitro aniline
o-nitro-aniline
o-nitro aniline
2nitroaniline
2-nitro-anilin
1-nitro-2-aminobenzene
o-nitranilin
2-nitro-benzeneamine
AM87359
Q-201516
F2190-0432
mfcd00007687
2-nitroaniline, 99%
BCP05324
Q2590230
STR00840
D97708
EN300-17394
bdbm50554334
38500-40-2
2-nitroaniline-al-14c
Z56924541

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"0), Ni/Fe dosage (1-5 g x L(-1)) and reaction time (0."( [Removal of AOX and Chroma in Biologically Treated Effluent of Chemical Dyestuff Wastewater with Nanoscale Ni/Fe].
Chen, LJ; Liu, R; Shu, XM; Xu, CC; Zhao, Y, 2016
)
0.43
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (9)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
interleukin 8Homo sapiens (human)Potency0.02110.047349.480674.9780AID651758
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency0.83680.000214.376460.0339AID588532; AID720692
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency54.48270.003041.611522,387.1992AID1159553
farnesoid X nuclear receptorHomo sapiens (human)Potency0.00070.375827.485161.6524AID588526
pregnane X nuclear receptorHomo sapiens (human)Potency69.14800.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency61.13060.000229.305416,493.5996AID743080
thyroid stimulating hormone receptorHomo sapiens (human)Potency1.90670.001628.015177.1139AID1259385
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency16.35680.000323.4451159.6830AID743065; AID743067
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Transcriptional activator protein LuxRAliivibrio fischeriIC50 (µMol)85.00001.36003.25337.0000AID1699032
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (12)

Assay IDTitleYearJournalArticle
AID23254Partition coefficient (logP) (chloroform)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID237685Lipophilicity determined as logarithm of the partition coefficient in the alkane/water system2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
AID23255Partition coefficient (logP) (ether)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID23252Partition coefficient (logP) (benzene)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID288191Membrane retention in permeability experiment with artificial membrane2007Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11
QSAR study on permeability of hydrophobic compounds with artificial membranes.
AID23251Partition coefficient (logP)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID288184Permeability coefficient through artificial membrane in presence of unstirred water layer by PAMPA2007Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11
QSAR study on permeability of hydrophobic compounds with artificial membranes.
AID288185Permeability coefficient through artificial membrane in presence of stirred water layer2007Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11
QSAR study on permeability of hydrophobic compounds with artificial membranes.
AID288192Partition coefficient, log P of the compound2007Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11
QSAR study on permeability of hydrophobic compounds with artificial membranes.
AID23253Partition coefficient (logP) (carbon tetrachloride)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID1699032Antagonist activity at Vibrio fischeri luxR expressed in Escherichia coli NM522 in presence of 3-oxo-C6-HSL2020Bioorganic & medicinal chemistry, 11-01, Volume: 28, Issue:21
Next generation quorum sensing inhibitors: Accounts on structure activity relationship studies and biological activities.
AID23256Partition coefficient (logP) (hexane)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (12.50)18.7374
1990's0 (0.00)18.2507
2000's2 (12.50)29.6817
2010's8 (50.00)24.3611
2020's4 (25.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 49.46

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index49.46 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index5.16 (4.65)
Search Engine Demand Index72.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (49.46)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (11.76%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (88.24%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]